BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:65829
DTSTAMP:20260915T181252Z
SUMMARY:Seminar on Clinical Drug Development and Approval Process at W
 ashington
DESCRIPTION:Overview:\nDrug development is the process of incorporatin
 g data from multiple disciplines into a logical and coherent argument 
 for the efficacy and safety of a drug product resulting in regulatory 
 approval. The course will focus on the clinical aspect. The primary go
 al of the course will provide students with the basic principles and p
 rocess for taking a chemical and developing it into a drug product. Me
 dical, pharmaceutical, pharmacokinetics, and statistical principles wi
 ll be reviewed and utilized in the course. Examples will be provided b
 y my experience, experiences in the literature, and approvals from the
  Food and Drug Administration (FDA) website.\nWhy you should attend:\n
 This seminar provides you with an understanding of the process. People
  often use the term, \"Well, it's not rocket science!\", to indicate t
 hat something is not complicated. They could also use the term \"Well,
  it's not drug development!\" The process of clinical drug development
  utilizes pharmacokinetics, medical, statistics, and other clinically 
 relevant principles to turn a chemical compound into a safe and effect
 ive drug.\nSpeaker:\nRobert L. Kunka, Ph.D., is an accomplished and r
 espected scientist who contributed to the development of 28 pharmaceut
 ical products in eight therapeutic areas. His expertise on internation
 al product development teams produced submissions with successful clin
 ical strategies, sound matrix management of individual study teams, an
 d effective interactions with regulatory agencies leading to successfu
 l IND, aNDA, and NDA approvals.\nPrice: $1,295.00 (Seminar for One Del
 egate)\nRegister now and save $200. (Early Bird)\nUntil June 10, Early
  Bird Price: $1,295.00\nFrom June 11 to July 21, Regular Price: $1,495
 .00\nContact Information:\nNetZealous LLC,\nDBA GlobalCompliancePanel\
 n161 Mission Falls Lane,\nSuite 216, Fremont, CA 94539, USA     Â
  Â Â Â \nUSA Phone: 800-447-9407\nFax: 302-288-6884\nsupport@globalcom
 pliancepanel.com          \nhttp://www.globalcompliancepanel
 .com\nEvent Registration Link - http://bit.ly/1zzZDvv\n \n \n \n \
 n\nFor more information visit https://medtechiq.ning.com/events/semina
 r-on-clinical-drug-development-and-approval-process-at
DTSTART;TZID=America/New_York:20150723T090000
DTEND;TZID=America/New_York:20150724T180000
CATEGORIES:clinical, food, fda, medical, device, defence, and, navy, a
 erospace, mining
LOCATION:Washington DC
WEBSITE:https://www.globalcompliancepanel.com
URL:https://www.globalcompliancepanel.com
CONTACT:18004479407
ORGANIZER:GlobalCompliancePanel
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562011438?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="John Rob
 inson":https://medtechiq.ning.com/profile/JohnRobinson
END:VEVENT
END:VCALENDAR